Open AccessDaratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study
Author(s) -
Marco Cerrano,
Massimiliano Bonifacio,
Matteo Olivi,
Antonio Curti,
Michele Malagola,
Michelina Dargenio,
Anna Maria Scattolin,
Cristina Papayannidis,
Fabio Forghieri,
Carmela Gurrieri,
Ilaria Tanasi,
Patrizia Zappasodi,
Roberta La Starza,
Nicola Stefano Fracchiolla,
Patrizia Chiusolo,
Luisa Giaccone,
Maria Ilaria Del Principe,
Fabio Giglio,
Marzia Defina,
Claudio Favre,
Carmelo Rizzari,
Barbara Castella,
Giovanni Pizzolo,
Felicetto Ferrara,
Sabina Chiaretti,
Robin Foà
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.279851
Subject(s) - daratumumab , medicine , lymphoblastic leukemia , chemotherapy , observational study , oncology , retrospective cohort study , refractory (planetary science) , leukemia , dexamethasone , lenalidomide , astrobiology , physics
Not available.